MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug combo halted early in High-Risk blood disorder trial
Disease control TerminatedThis study aimed to test the safety and effectiveness of a new drug, sabatolimab, when given with two other drugs (azacitidine and venetoclax) for adults with high-risk myelodysplastic syndrome (MDS), a serious bone marrow disorder. The trial was designed for patients who were no…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Drug trial for blood disorder halted early
Disease control TerminatedThis study tested whether adding an experimental drug called sabatolimab to standard treatments could help control a serious blood and bone marrow disorder called myelodysplastic syndrome (MDS). It involved 39 adults with intermediate to very high-risk MDS. The trial was terminat…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC